Cargando…
RNA in Cancer Immunotherapy: Unlocking the Potential of the Immune System
Recent advances in the manufacturing, modification, purification, and cellular delivery of ribonucleic acid (RNA) have enabled the development of RNA-based therapeutics for a broad array of applications. The approval of two SARS-CoV-2–targeting mRNA-based vaccines has highlighted the advances of thi...
Autores principales: | De Mey, Wout, Esprit, Arthur, Thielemans, Kris, Breckpot, Karine, Franceschini, Lorenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475240/ https://www.ncbi.nlm.nih.gov/pubmed/35583609 http://dx.doi.org/10.1158/1078-0432.CCR-21-3304 |
Ejemplares similares
-
Neo-Antigen mRNA Vaccines
por: Esprit, Arthur, et al.
Publicado: (2020) -
An mRNA mix redirects dendritic cells towards an antiviral program, inducing anticancer cytotoxic stem cell and central memory CD8(+) T cells
por: de Mey, Wout, et al.
Publicado: (2023) -
A synthetic DNA template for fast manufacturing of versatile single epitope mRNA
por: de Mey, Wout, et al.
Publicado: (2022) -
The role of SMAC mimetics in regulation of tumor cell death and immunity
por: Emeagi, Perpetua U., et al.
Publicado: (2012) -
Single-Domain Antibody Nuclear Imaging Allows Noninvasive Quantification of LAG-3 Expression by Tumor-Infiltrating Leukocytes and Predicts Response of Immune Checkpoint Blockade
por: Lecocq, Quentin, et al.
Publicado: (2021)